過食性障害市場：製品、エンドユーザー、流通チャネル別-2025-2030年世界予測

過食性障害市場は、2023年に5億5,642万米ドルと評価され、2024年には5億8,785万米ドルに達すると予測され、CAGR 5.98％で成長し、2030年には8億3,576万米ドルに達すると予測されています。

過食性障害（BED）は、コントロール不能感を伴いながら、しばしば不快感を感じるほど急速に大量の食物を食べる再発性のエピソードを特徴とします。BEDは代償行動（例：パージ）を伴わないため、他の摂食障害とは一線を画しています。BEDの市場を理解する必要性は、BEDが身体的健康に重大な影響を及ぼす重大な精神衛生上の問題として認識されつつあり、効果的な治療、療法、介入が必要とされていることに起因します。ヘルスケア、心理社会的療法、栄養療法が主な用途であり、医療提供者、診療所、リハビリセンターなどの最終用途に幅広い範囲を提供しています。市場成長は、認知度の向上、診断普及率の改善、政府機関や保健機関による資金提供や研究イニシアチブの高まりによって影響を受けています。特に、北米と欧州地域は、先進的なヘルスケアシステムとメンタルヘルス障害に対する積極的な対策により、市場拡大をリードしています。遠隔医療サービスの増加、新規治療法の開発、遺伝子や表現型を手がかりに介入策を調整する個別化医療アプローチにビジネスチャンスがあります。企業は、デジタル・ヘルス・アプリケーションや最先端の医薬品に投資することで、これらを活用することができます。とはいえ、社会的偏見、不十分な保険適用、一部の層における認識不足といった課題は依然として残っており、これが市場浸透と治療導入の妨げとなっています。また、規制のハードルや医薬品の研究開発コストの高さからも限界が生じる。しかし、こうした障壁は、アクセシビリティと費用対効果を高めることができるデジタル行動介入プラットフォームや、AI主導の診断ツールなど、潜在的なイノベーション分野に火をつける。この市場は、精神医学、栄養学、テクノロジーを融合させた学際的アプローチを重視する統合的な性格を有しており、新たな治療情勢の機会において事業の成長を促進する異業種間の協力に道を開いています。

市場力学：急速に進化する過食性障害市場の主要市場インサイトを公開

過食性障害市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 過食性障害に関する公衆衛生キャンペーンと教育活動の増加
  • メンタルヘルスサービスに対するヘルスケア支出および保険適用の増加
  • BED治療に対する個別化された患者中心のアプローチへの注目の高まり
• 市場抑制要因
  • 過食性障害治療に伴う高コスト
• 市場機会
  • 過食性障害治療のためのデジタルヘルスソリューションの出現と統合
  • ヘルスケアプロバイダー、研究者、BED治療および啓発団体間のパートナーシップの拡大
• 市場の課題
  • 過食性障害治療に対する偏見と認識不足

ポーターのファイブフォース：過食性障害市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、過食性障害市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：過食性障害市場における外部からの影響の把握

外部マクロ環境要因は、過食性障害市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析過食性障害市場における競合情勢の把握

過食性障害市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス過食性障害市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、過食性障害市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨過食性障害市場における成功への道筋を描く

過食性障害市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 過食性障害に関する公衆衛生キャンペーンと教育活動の強化
    • メンタルヘルスサービスに対するヘルスケア費と保険適用範囲の拡大
    • BED治療における個別化された患者中心のアプローチへの注目が高まる
  • 抑制要因
    • 過食性障害治療に伴う高コスト
  • 機会
    • 過食性障害治療のためのデジタルヘルスソリューションの出現と統合
    • BEDの治療と啓発のためのヘルスケア提供者、研究者、支援団体間のパートナーシップの拡大
  • 課題
    • 過食性障害治療に関する偏見と認識不足
• 市場セグメンテーション分析
  • 製品：BEDおよび併存疾患を正確に特定するための効率的な診断の必要性
  • エンドユーザー：BED患者の複雑なニーズに対応するために不可欠な、包括的なサービスを提供する病院に対する高い選好
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 過食性障害市場：製品別

• 診断
• 治療
  • 医薬品
    • 抗けいれん薬
    • 抗うつ薬
  • 心理療法
    • 認知行動療法
    • 弁証法的行動療法
    • 対人関係心理療法

第7章 過食性障害市場：エンドユーザー別

• 病院
• オンラインセラピープラットフォーム
• 専門クリニック
• サポートグループ

第8章 過食性障害市場流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 南北アメリカの過食性障害市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の過食性障害市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの過食性障害市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • EDCareはコロラド州、カンザス州、ネブラスカ州でバーチャル集中外来プログラムによる摂食障害治療を拡大し、長期回復のためのアクセス性と柔軟性を向上
  • Axsome TherapeuticsのSolriamfetolの第3相試験は、米国の成人における過食性障害に対処することを目指しており、FDAの承認を得る可能性があります。
  • モンテ・ニド＆アフィリエイツ、ヒューストンに新たなデイ治療施設を開設し摂食障害治療を拡大
  • Equipパートナーシップにより、Accoladeの信頼できるパートナーエコシステムに摂食障害サポートが追加
  • インサイドアウト研究所の800万米ドルの資金提供により摂食障害への支援が強化される
• 戦略分析と提言

企業一覧

• Alsana, Inc.
• Alvogen
• Amneal Pharmaceuticals, Inc.
• Apotex Inc.
• Ascent Pharmaceuticals, Inc.
• BALANCE Eating Disorder Treatment Center
• Carolina House Eating Disorder Treatment Center
• Center for Change
• Eating Disorders Treatment Center
• Eating Recovery Center
• Equip Health Medical, P.C.
• Hikma Pharmaceuticals PLC
• Mallinckrodt PLC
• Monte Nido & Affiliates Holdings, LLC
• Montecatini Eating Disorder Treatment Center
• Natural Food Therapy
• Red Oak Recovery
• Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• TalktoAngel
• The London Centre for Eating Disorders and Body Image Ltd.
• Timberline Knolls Residential Treatment Center
• Veritas Collaborative
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. BINGE EATING DISORDER MARKET RESEARCH PROCESS
• FIGURE 2. BINGE EATING DISORDER MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BINGE EATING DISORDER MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BINGE EATING DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BINGE EATING DISORDER MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BINGE EATING DISORDER MARKET DYNAMICS
• TABLE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTICONVULSANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIALECTICAL BEHAVIOR THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE THERAPY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SUPPORT GROUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 80. CHINA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 82. CHINA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 83. CHINA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 84. CHINA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. CHINA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 86. INDIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 88. INDIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 89. INDIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 90. INDIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. INDIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 189. ITALY BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 191. ITALY BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 192. ITALY BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 193. ITALY BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. ITALY BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 213. POLAND BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 215. POLAND BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 216. POLAND BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 217. POLAND BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. POLAND BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 219. QATAR BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 221. QATAR BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 222. QATAR BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 223. QATAR BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. QATAR BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 279. BINGE EATING DISORDER MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 280. BINGE EATING DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

The Binge Eating Disorder Market was valued at USD 556.42 million in 2023, expected to reach USD 587.85 million in 2024, and is projected to grow at a CAGR of 5.98%, to USD 835.76 million by 2030.

Binge Eating Disorder (BED) is characterized by recurrent episodes of eating large quantities of food, often quickly and to the point of discomfort, accompanied by a feeling of loss of control. BED is distinct as it involves no compensatory behaviors (e.g., purging), diverging from other eating disorders. The necessity for understanding BED's market stems from its growing recognition as a critical mental health issue with significant physical health implications, necessitating effective treatments, therapies, and interventions. Pharmaceuticals, psycho-social therapies, and nutritional treatments are primary applications, providing a broad scope for end-use among healthcare providers, clinics, and rehabilitation centers. The market growth is influenced by increasing awareness, improved diagnostic prevalence rates, and the rising funding and research initiatives by governmental bodies and health organizations. Notably, the North American and European regions lead in market expansion due to advanced healthcare systems and proactive measures against mental health disorders. Opportunities lie in increased telemedicine services, the development of novel therapies, and personalized medicine approaches, relying on genetic and phenotypic cues to tailor interventions. Companies can capitalize on these by investing in digital health applications and cutting-edge pharmaceuticals. Nevertheless, challenges persist in the form of societal stigma, inadequate insurance coverage, and a lack of awareness in some demographics, which hinder market penetration and treatment adoption. Limitations also arise from regulatory hurdles and the high cost of research and development in pharmaceuticals. However, these barriers spark potential innovation areas, such as digital behavioral intervention platforms, which can increase accessibility and cost-effectiveness, and AI-driven diagnostic tools. The market is integrative by nature, emphasizing a multidisciplinary approach-merging psychiatry, nutrition, and technology-which paves the way for cross-industry collaborations to fuel business growth in emerging therapeutic landscape opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Binge Eating Disorder Market

The Binge Eating Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing public health campaigns and education efforts around binge eating disorder
  • Rising healthcare expenditure and insurance coverage for mental health services
  • Increasing focus on personalized, patient-centered approaches to BED treatment
• Market Restraints
  • High cost associated with binge eating disorder treatments
• Market Opportunities
  • Emergence and integration of digital health solutions for binge eating disorder treatments
  • Growing partnerships between healthcare providers, researchers, and advocacy groups for BED treatment and awareness
• Market Challenges
  • Stigma and lack of awareness about binge eating disorder treatments

Porter's Five Forces: A Strategic Tool for Navigating the Binge Eating Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Binge Eating Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Binge Eating Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Binge Eating Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Binge Eating Disorder Market

A detailed market share analysis in the Binge Eating Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Binge Eating Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Binge Eating Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Binge Eating Disorder Market

A strategic analysis of the Binge Eating Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Binge Eating Disorder Market, highlighting leading vendors and their innovative profiles. These include Alsana, Inc., Alvogen, Amneal Pharmaceuticals, Inc., Apotex Inc., Ascent Pharmaceuticals, Inc., BALANCE Eating Disorder Treatment Center, Carolina House Eating Disorder Treatment Center, Center for Change, Eating Disorders Treatment Center, Eating Recovery Center, Equip Health Medical, P.C., Hikma Pharmaceuticals PLC, Mallinckrodt PLC, Monte Nido & Affiliates Holdings, LLC, Montecatini Eating Disorder Treatment Center, Natural Food Therapy, Red Oak Recovery, Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, TalktoAngel, The London Centre for Eating Disorders and Body Image Ltd., Timberline Knolls Residential Treatment Center, Veritas Collaborative, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Binge Eating Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diagnostics and Treatments. The Treatments is further studied across Medications and Psychotherapy. The Medications is further studied across Anticonvulsant and Antidepressants. The Psychotherapy is further studied across Cognitive Behavioral Therapy, Dialectical Behavior Therapy, and Interpersonal Psychotherapy.
• Based on End-User, market is studied across Hospitals, Online Therapy Platforms, Specialty Clinics, and Support Groups.
• Based on Distribution Channels, market is studied across Hospitals Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing public health campaigns and education efforts around binge eating disorder
    • 5.1.1.2. Rising healthcare expenditure and insurance coverage for mental health services
    • 5.1.1.3. Increasing focus on personalized, patient-centered approaches to BED treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with binge eating disorder treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence and integration of digital health solutions for binge eating disorder treatments
    • 5.1.3.2. Growing partnerships between healthcare providers, researchers, and advocacy groups for BED treatment and awareness
  • 5.1.4. Challenges
    • 5.1.4.1. Stigma and lack of awareness about binge eating disorder treatments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Need for efficient diagnosis to accurately identify BED and any comorbid conditions
  • 5.2.2. End-User: Higher preferences for hospitals with comprehensive services, essential for addressing the complex needs of BED patients
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Binge Eating Disorder Market, by Product

• 6.1. Introduction
• 6.2. Diagnostics
• 6.3. Treatments
  • 6.3.1. Medications
    • 6.3.1.1. Anticonvulsant
    • 6.3.1.2. Antidepressants
  • 6.3.2. Psychotherapy
    • 6.3.2.1. Cognitive Behavioral Therapy
    • 6.3.2.2. Dialectical Behavior Therapy
    • 6.3.2.3. Interpersonal Psychotherapy

7. Binge Eating Disorder Market, by End-User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Online Therapy Platforms
• 7.4. Specialty Clinics
• 7.5. Support Groups

8. Binge Eating Disorder Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospitals Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas Binge Eating Disorder Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Binge Eating Disorder Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Binge Eating Disorder Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. EDCare expands eating disorder treatment with virtual intensive outpatient programs in Colorado, Kansas, and Nebraska, improving accessibility and flexibility for long-term recovery
  • 12.3.2. Axsome Therapeutics' Phase 3 trial of Solriamfetol aims to address binge eating disorder in US adults, potentially securing FDA approval
  • 12.3.3. Monte Nido & Affiliates Expands Eating Disorder Treatment with New Day Treatment Location in Houston
  • 12.3.4. Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem
  • 12.3.5. InsideOut Institute's USD 8 Million Funding Enhances Support for Eating Disorders
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alsana, Inc.
• 2. Alvogen
• 3. Amneal Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Ascent Pharmaceuticals, Inc.
• 6. BALANCE Eating Disorder Treatment Center
• 7. Carolina House Eating Disorder Treatment Center
• 8. Center for Change
• 9. Eating Disorders Treatment Center
• 10. Eating Recovery Center
• 11. Equip Health Medical, P.C.
• 12. Hikma Pharmaceuticals PLC
• 13. Mallinckrodt PLC
• 14. Monte Nido & Affiliates Holdings, LLC
• 15. Montecatini Eating Disorder Treatment Center
• 16. Natural Food Therapy
• 17. Red Oak Recovery
• 18. Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
• 19. Sun Pharmaceutical Industries Ltd.
• 20. Takeda Pharmaceutical Company Limited
• 21. TalktoAngel
• 22. The London Centre for Eating Disorders and Body Image Ltd.
• 23. Timberline Knolls Residential Treatment Center
• 24. Veritas Collaborative
• 25. Viatris Inc.